DHG Pharmaceutical JSC (DHG) — Cash Flow Quality Index
DHG Pharmaceutical JSC (DHG) has a Cash Flow Quality Index of 2.42x as of December 2025. Operating cash flow of ₫447.50 Billion exceeds net income of ₫184.80 Billion, indicating high earnings quality where cash backs reported profits. Also explore DHG current and non-current assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
DHG Pharmaceutical JSC Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for DHG Pharmaceutical JSC across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of DHG Pharmaceutical JSC to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for DHG Pharmaceutical JSC (2019–2025)
Year-by-year earnings quality comparison for DHG Pharmaceutical JSC. For live market cap and the full company financial profile, see DHG Pharmaceutical JSC stock valuation.
| Year | Quality Index | Operating CF (VND) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.36x | ₫1.22 Trillion | ₫897.58 Billion | ▼ -19.4% |
| 2024 | 1.69x | ₫1.32 Trillion | ₫778.92 Billion | ▲ +535.5% |
| 2023 | 0.27x | ₫279.88 Billion | ₫1.05 Trillion | ▼ -70.8% |
| 2022 | 0.91x | ₫901.28 Billion | ₫988.45 Billion | ▲ +56.6% |
| 2021 | 0.58x | ₫452.44 Billion | ₫777.22 Billion | ▼ -47.9% |
| 2020 | 1.12x | ₫826.17 Billion | ₫739.87 Billion | ▼ -15.4% |
| 2019 | 1.32x | ₫838.24 Billion | ₫635.39 Billion | — |